Studies on antihypertensive effect of luobuma (Apocynum venetum L.) leaf extract (3)

Yakugaku Zasshi

Volumn 124, Issue 11, 2004, Pages 851-856

  Tagawa, Chie ^a   Kagawa, Tamami ^b   Nakazawa, Yoshihisa ^a   Onizuka, Shigenori ^a   Nishibe, Sansei ^c   Kawasaki, Hiromu ^d  

^a Hitachi Zosen Corporation   (Japan)

^b DyDo DRINCO INC   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antihypertensive effect; Apocynum venetum L.; Endothelium dependent relaxation; Luobuma leaf extract; Rat mesenteric vascular bed

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOCYNUM VENETUM EXTRACT; ATROPINE; DEOXYCHOLATE SODIUM; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HERBACEOUS AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; TETRYLAMMONIUM; UNCLASSIFIED DRUG; BIOLOGICAL FACTOR; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; POTASSIUM CHLORIDE;

ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; APOCYNACEAE; APOCYNUM VENETUM; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; HYPERPOLARIZATION; MEDICINAL PLANT; MESENTERY BLOOD FLOW; NONHUMAN; PLANT LEAF; RAT; TISSUE PERFUSION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; APOCYNUM; DOSE RESPONSE; IN VITRO STUDY; MALE; MESENTERIC ARTERY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOCYNUM; BIOLOGICAL FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNELS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; VASCULAR RESISTANCE; VASODILATION;

EID: 16644375627     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.124.851     Document Type: Article

References (15)

1. Jiangsu New Medical Collage, "Chinese Materia Medicine Dictionary," ed., Shanghai Science and Technology Pubulishing House, Shanghai, 1978, pp. 1355-1356.
2. Chinese Pharmacopeia Committee of Ministry of Public Health of the People's Republic of China, "The Chinese Pharmacopeia, Vol. 1," Chemical and Technical Press, Beijing, 2000, p. 170.
3. Compilation of Luobuma Utilization Edited Group, "Total Utilazation of Luobuma," ed., Science Press, Beijing, 1978, pp. 57-92.
4. Khasbagan., Huai Hu.-Yin., Pei Sheng-Ji., Econ. Bot., 54, 528-536 (2000).
5. Kagawa T., Nakazawa Y., Tagashira E., Takahashi Y., Onizuka S., Nishibe S., Nat. Med., 58, 109-112 (2004).
6. Kagawa T., Nakazawa Y., Tagashira E., Takahashi Y., Onizuka S., Nishibe S., Nat. Med., 58, inpress.
7. Nishibe S., Takemura H., Fujimoto T., Sasahara M., Tanaka T., Shoyakugaku Zasshi, 47, 27-33 (1993).
8. Hoki S., Kimura T., Nagasawa M., Kozaki K., Terashima N., Nat. Med., 58, 113-114 (2004).
9. Taubert D., Berkels R., Klaus W., Roesen R., J. Cardiovasc. Pharmacol., 40, 701-713 (2002).
10. Kemp B. K., Cocks T. M., Br. J. Pharmcol., 120, 757-762 (1997).
11. Kawasaki H., Takasaki K., Saito S., Goto K., Nature, 335, 164-167 (1988).
12. Ralevic V., Burnstock G., Circ. Res., 69, 1583 -1590 (1991).
13. Byfield R. A., Swayne G. T. G., Warner T. J., Br. J. Pharmacol., 88, 438 (1986).
14. Shimokawa H., Ysutake H., Fujii K., Owada M. K., Nakaike R., Tagayanagi T., Nagoya T., Egashira K., Fujishima M., Takeshita A., J. Cardiovasc. Pharmacol., 28, 703-711 (1996).
15. Hwa J. J., Ghibaudi L., Williams P., Chatterjee M., Am. J. Physiol. Heart Circ. Physiol., 266, 952-958 (1994).